| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/30/2007 | US7169798 Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases |
| 01/30/2007 | US7169795 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 01/30/2007 | US7169787 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 01/30/2007 | US7169779 Inhibitors of p38 |
| 01/30/2007 | US7169776 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 01/30/2007 | US7169772 Vasopressin active material; antidiabetic agents; diuretics; bioavailability |
| 01/30/2007 | US7169758 Use of hepcidin as a regulator of iron homeostasis |
| 01/30/2007 | US7169754 Blood disorders; drug in aqueous solution |
| 01/30/2007 | US7169572 Assays for determining anticoagulant cofactor activity |
| 01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
| 01/30/2007 | US7169389 Human CD154 binding molecules and treatment methods |
| 01/30/2007 | US7169387 Monoclonal antibodies orsoluble immunoglobulin fusion protein; block multiple sclerosis |
| 01/30/2007 | CA2289623C A new process for the preparation of a pharmacologically active substance |
| 01/25/2007 | WO2007009883A1 Novel heteroaryl fused cyclic amines |
| 01/25/2007 | WO2007009707A2 Use of substituted pyrazoline compounds for the treatment of coagulation related diseases |
| 01/25/2007 | WO2007009635A1 Phenyl substituted piperazine-derivatives as inhibitors of plaminogenic activator inhibitors-i (pai-i) |
| 01/25/2007 | WO2006128885A3 Uses of oligonucleotides stimulatory of the mesenchymal stem cell proliferation |
| 01/25/2007 | WO2006114415A3 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester |
| 01/25/2007 | WO2006033005A3 Thrombopoietin receptor agonists |
| 01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/25/2007 | US20070021472 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070020703 Use of compositions comprising a soluble form of hla-g in the treatment of blood diseases |
| 01/25/2007 | US20070020270 Human serpin polypeptides |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |
| 01/25/2007 | US20070020260 Glycoprotein compositions |
| 01/25/2007 | DE102005033371A1 Substituierte Pyridocarboxamide Substituted Pyridocarboxamide |
| 01/25/2007 | CA2615447A1 Substituted amides, their preparation and their use as pharmaceuticals |
| 01/25/2007 | CA2614939A1 Phenyl substituted piperazine-derivatives as inhibitors of plaminogenic activator inhibitors-i (pai-i) |
| 01/25/2007 | CA2614401A1 Novel heteroaryl fused cyclic amines |
| 01/24/2007 | EP1746108A1 Fish-origin chondroitin sulfate/dermatan sulfate hybrid chain |
| 01/24/2007 | EP1746095A1 Indanol derivative |
| 01/24/2007 | EP1745076A2 Antibodies specific for glycoprotein vi and methods of producing these antibodies |
| 01/24/2007 | EP1744752A2 A method for the prevention of thromboembolic disorders |
| 01/24/2007 | EP1744729A2 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 01/24/2007 | EP1506183B1 Method of forming iron hydroxypyrone compounds |
| 01/24/2007 | EP1370570B1 Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein c |
| 01/24/2007 | EP1341537B1 Pharmaceutically active isoindoline derivatives |
| 01/24/2007 | EP1295126B1 Hepatitis c viral antigen immunoassay detection systems |
| 01/24/2007 | EP1180028B1 Il-8 receptor antagonists |
| 01/24/2007 | CN1902191A Amidopyrazole derivative |
| 01/24/2007 | CN1901881A Compositions and dosage forms for enhanced absorption |
| 01/24/2007 | CN1900074A Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/24/2007 | CN1899615A Preparation for the prophylaxis of restenose |
| 01/24/2007 | CN1899614A Preparation for the prophylaxis of restenose |
| 01/24/2007 | CN1899583A Blood vessel clearing capsule of pure Chinese medicine |
| 01/24/2007 | CN1899557A Chinese medicine preparation for treating leukemia |
| 01/24/2007 | CN1899477A Musk ointment for removing toxic substances and removing blood stasis |
| 01/24/2007 | CN1899410A Medicine for treating cardiovascular disease and its preparing method and quality control method |
| 01/24/2007 | CN1899398A Medicine for treating cerebral thrombosis |
| 01/24/2007 | CN1899390A External use analgesic hemostatic preparation and its preparing method |
| 01/24/2007 | CN1899360A Process for preparing water soluble composite agent capable of replacing plasma |
| 01/24/2007 | CN1899359A Taiyi pill |
| 01/24/2007 | CN1899357A Method for producing persimmon frost medicine |
| 01/24/2007 | CN1899352A Chinese medicine effective part composition for supplementing qi and recovering pulse |
| 01/24/2007 | CN1899350A Chinese medicine for preventing subcutaneous hemorrhage after pulling out needle |
| 01/24/2007 | CN1899310A Active ass-hide glue flavone nutrition capsule |
| 01/24/2007 | CN1899306A Use of carbon and carbon containing matter inpreparing medicine for treating human body hemorrhagic syndrome and preparation and preparing method |
| 01/24/2007 | CN1899293A Use of lambda-carrageenan oligose in preparing blood vessel proliferation inhibitor |
| 01/24/2007 | CN1899280A Use of chlorogenic acid in preparing medicine for improving bone marrow cell efficiency |
| 01/24/2007 | CN1899274A Use of gingerol oxime in preparing anti-blood platelet aggregation medicine |
| 01/24/2007 | CN1296361C Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 01/24/2007 | CN1296354C Pharmaceutically active pyrrolidine derivatives as BAX inhibitors |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/24/2007 | CN1296082C Medication and health food in use for lowering blood sugar, improving function of intestinal tract and reducing platelet aggergation |
| 01/24/2007 | CN1296069C Cassia twig and tuckahoe composition and its preparing technics |
| 01/24/2007 | CN1296039C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/24/2007 | CN1296036C Compound sophora root freeze-drying injection |
| 01/23/2007 | US7166709 Using high preformance liquid chromatography and gel permeation to purify heat resistant von willebrand factor (VDF) and antihemophilic factor from virally deactivated mixture; treating blood disorders |
| 01/23/2007 | US7166632 such as (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C); for treatment of obesity |
| 01/23/2007 | US7166623 Pain and inflammation |
| 01/23/2007 | US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 01/23/2007 | US7166613 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands |
| 01/23/2007 | US7166606 Certain 1-(D-cycloproplyglycinyl)-4-piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor Xa |
| 01/23/2007 | US7166597 Antiinflammatory agents; autoimmune disease treatments; pyrazolo(1,5-a)pyridine derivatives |
| 01/23/2007 | US7166592 Antiinflammatory agents |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | CA2191747C (a)-annelated pyrrole derivatives and pharmaceutical use thereof |
| 01/18/2007 | WO2007008146A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007008145A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007008144A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007008143A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007008142A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007008140A1 New pyridine analogues |
| 01/18/2007 | WO2007008045A1 Pharmaceutical compositions containing clopidogrel bisulfate |
| 01/18/2007 | WO2007007588A1 Compound having cyclic group with planarity as core |
| 01/18/2007 | WO2006036926A3 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 01/18/2007 | US20070015816 Antibody specific for 4-methyl-3-vinylmaleimide derivatives; photolabile degradation product of bilirubin or biliverdin; antiinflammatory agents, infections,systemic inflammatory response syndrome |
| 01/18/2007 | US20070015772 Nucleoside metabolism inhibitors |
| 01/18/2007 | US20070015766 Quinoline Derivatives as NK-3 and NK-2 Antagonists |
| 01/18/2007 | US20070015732 Adenosine receptor antagonists and methods of making and using the same |
| 01/18/2007 | US20070015714 Methods for treating FSH related conditions with GnRH antagonists |
| 01/18/2007 | US20070014793 Antibodies which activate an erythropoietin receptor |
| 01/18/2007 | US20070014783 Use of collagenase to facilitate guide wire crossing in total arterial occlusions |
| 01/18/2007 | DE102005047945A1 Verwendung von Aktivatoren der löslichen Guanylatzyklase zur Behandlung von Raynaud Phänomenen Use of activators of soluble guanylate cyclase for the treatment of Raynaud's phenomenon |
| 01/18/2007 | CA2614726A1 New pyridine analogues |
| 01/17/2007 | EP1743639A1 Use of substituted pyrazoline compounds for the treatment of coagulation related diseases |
| 01/17/2007 | EP1743632A1 Novel 4-dedimethy laminotetracycline derivatives |
| 01/17/2007 | EP1441667B1 Improved endoprosthetic device |
| 01/17/2007 | EP1400518B1 Heterocyclic compound derivatives and medicines |